Showing results (161-170 of 321) with videos related to
Sort By:
Pageof 33
Surgery|January 1, 1977
Prolonged survival of xenografts after organ cultureH W Sollinger, P M Burkholder, W R Rasmus, et al.Scandinavian Journal of Immunology|January 1, 1980
Family of large surface proteins on human lymphocytesB Koller, B Dunlap, J Hank, et al.Transplantation|September 1, 1991
Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejectionA P Dalmasso, G M Vercellotti, J L Platt, et al.Human Immunology|September 1, 1986
DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphismsM Segall, H Noreen, L Schluender, et al.The Journal of Experimental Medicine|October 19, 1999
A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in isletsS T Grey, M B Arvelo, W Hasenkamp, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytesJ M Zarling, N E Kay, B Grant, et al.Transplantation|July 17, 1998
Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipientsT Miyatake, N Koyamada, W W Hancock, et al.Immunology Today|October 26, 2014
The stepwise activation of cytotoxic T lymphocytesG Gromo, L Inverardi, R L Geller, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitopeS K Wu, T Yabe, M Madden, et al.Pageof 33